Commerzbank Aktiengesellschaft’s Regeneron Pharmaceuticals REGN Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-15,000	Closed	-$398K	–	997
2019 Q2	$398K	Buy	+15,000	New	+$4.99M	﹤0.01%	788
2019 Q1	–	Sell	-37,700	Closed	-$411K	–	967
2018 Q4	$411K	Hold	37,700	–	–	﹤0.01%	699
2018 Q3	$391K	Buy	37,700 +17,800	+89%	+$6.77M	﹤0.01%	732
2018 Q2	$244K	Buy	+19,900	New	+$6.22M	﹤0.01%	809

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Commerzbank Aktiengesellschaft's REGN Position: Q1 2026 in Review

Commerzbank Aktiengesellschaft reduced its Regeneron Pharmaceuticals (REGN) stake by 6.7% in Q1 2026, selling an estimated $29.9K and leaving 539 shares worth $416K. The position accounts for 0.01% of the portfolio, ranked #277.

Commerzbank Aktiengesellschaft first reported a position in REGN in Q2 2013 and has held it in 36 quarters since. The position peaked at $33.9M in Q2 2015. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Commerzbank Aktiengesellschaft held 539 shares of Regeneron Pharmaceuticals worth $416K as of Q1 2026.
Commerzbank Aktiengesellschaft sold 39 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $29.9K.
Regeneron Pharmaceuticals made up 0.01% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #277 holding.
Commerzbank Aktiengesellschaft first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 36 quarters since.
Commerzbank Aktiengesellschaft's Regeneron Pharmaceuticals position peaked at $33.9M in Q2 2015.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.